Takeda is a patient-centric, science-driven global biopharmaceutical company, founded in Osaka, Japan in 1781. Takeda is currently operating in more than 80 countries and regions worldwide, including the U.S., Europe, Latin America, Africa and Asia. In 2008, TakedacametoBulgaria.
Our values encompass Integrity, Fairness, Honesty, Perseverance, and our main priorities are Patient, Trust, Reputation, Business – in this order.
Takeda focuses its R&D efforts on five core therapeutic areas: Oncology, Hematology, Rare Diseases, Gastroenterology and Neuroscience, with targeted investments in Plasma-Derived Therapies and Vaccines.
Being a socially responsible and engaged company, Takeda has organised numerous activities, aimed at improving the quality of life of patients suffering from various diseases, as well as activities targeted at the general public.
The company is strongly engaged also with Japanese culture in Bulgaria, as well as with encouraging the development of business relations between Bulgaria and Japan.